REQUEST A DEMO
Total
USD $0.00
Search more companies

Uzdaroji Akcine Bendrove Abovita (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Uzdaroji Akcine Bendrove Abovita Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Uzdaroji Akcine Bendrove Abovita is based in Lithuania. The head office is in Vilnius. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on August 16, 2000. Uzdaroji Akcine Bendrove Abovita currently employs 3 (2025) people. The company’s latest financial report indicates a net sales revenue increase of 16.05% in 2024. Uzdaroji Akcine Bendrove Abovita’s net profit margin increased by 4.3% in 2024.

Headquarters
Zemaites g. 21-101
Vilnius; Vilnius county; Postal Code: LT-03118

Contact Details: Purchase the Uzdaroji Akcine Bendrove Abovita report to view the information.

Basic Information
Total Employees:
Purchase the Uzdaroji Akcine Bendrove Abovita report to view the information.
Registered Capital:
Purchase the Uzdaroji Akcine Bendrove Abovita report to view the information.
Financial Auditors:
Purchase the Uzdaroji Akcine Bendrove Abovita report to view the information.
Incorporation Date:
August 16, 2000
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Uzdaroji Akcine Bendrove Abovita report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
16.05%
Total Operating Revenue
16.05%
Net Profit/Loss for the Period
122.88%
Total Equity
116.88%
Net Profit Margin
4.3%
Return on Equity (ROE)
2.63%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?